ArticlePlastic and reconstructive surgery2026
Subtarsal Capsulopalpebral Fascia Incision: A New Paradigm for Ectropion-Free Transcutaneous Lower Blepharoplasty.
Article in Plastic and reconstructive surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLower-eyelid surgery by means of the transcutaneous approach is challenging because of common complications such as ectropion and scleral show.
methodsThe authors devised a transcutaneous lower-eyelid technique that incorporates 4 modifications that greatly reduce these complications-namely, tension-reducing incision of the capsulopalpebral fascia to prevent ectropion and preserve the pretarsal fullness; selective omission of lateral canthoplasty; universal application of arcuate expansion cuts to prevent lateral compartment bulging; and reattachment of the tear-trough and orbital-retaining ligaments to the orbital septum. A prospective cohort study was conducted on all consecutive patients who underwent the technique in January of 2020 to March of 2023. All complications were reviewed. The 50 most recent patients were assessed objectively by 3 independent plastic surgeons with regard to patient preoperative and 3- and 6-month postoperative tear trough, lid-cheek groove, eye bag, and fine lines. Each variable was scored on a 5-point scale.
resultsIn total, 340 patients underwent the procedure. No major complications, including ectropion, were observed. All 4 aesthetic variables improved significantly at 3 and 6 months relative to preoperative baseline.
conclusionsThis new approach significantly mitigates common complications of transcutaneous lower-eyelid operations, including persistent postoperative ectropion. Thus, it may be a promising advance in surgical correction of lower-eyelid aesthetics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.